期刊文献+

结肠癌细胞CDH1基因启动子甲基化对E-上皮钙黏素和β-连接素表达的调控作用 被引量:3

Regulation of CDH1 gene promoter methylation on expression of E-cadherin and β-catenin in human colon carcinoma ceils
原文传递
导出
摘要 目的观察结肠癌细胞中上皮钙黏素基因(CDH1)启动子甲基化对上皮钙黏素(E—cadherin)和β-连接素(β—catenin)表达的影响。方法通过甲基化特异性PCR(MSP)、逆转录-聚合酶链反应(RT—PCR)检测DNA甲基化抑制剂5-氮-2′-脱氧胞苷(5-Aza-CdR)干预前后人结肠癌HT-29细胞株CDH1基因启动子甲基化状态及E—cadherin mRNA的改变,并运用免疫荧光标记及激光共聚焦观察E—cadherin和β-catenin在细胞内的表达及分布。结果(1)HT-29细胞在用药前CDH1基因启动子甲基化扩增阳性,非甲基化扩增阴性,用5-Aza-CdR处理后CDH1基因启动子甲基化扩增阴性,非甲基化扩增阳性;(2)5-Aza—CdR处理前细胞RT—PCR不能扩增出E—cadherin mRNA特异性条带,5-Aza—CdR处理后则可检测到E—cadherinmRNA转录,且mRNA水平与药物的浓度呈正相关,平均灰度比值1μmol/L时为0.491±0.011,2μmol/L时为0.568±0.013(P〈0.05:(3)5-Aza-CdR处理前细胞未见E-cadherin表达,13-catenin主要表达于细胞质及细胞核中,5-Aza—CdR处理后在细胞膜可见E—cadherin及-catenin表达。且随着5-Aza—CdR诱导E-cadherin的表达,β-catenin在细胞膜的分布增加,而在细胞质及细胞核的分布明显减少。免疫荧光双重染色显示β-catenin胞膜分布与E—cadherin一致。结论CDH1基因启动子甲基化可能是导致结肠癌细胞E—cadherin表达缺失及β—catenin异位分布的重要因素。 Objective To observe the effects of CDH1 gene promoter methylation on the expres- sion of E-cadherin and β-catenin in human colon carcinoma cells. Methods Methylation specific PCR (MSP) and reverse transcription-polymerase chain reaction (RT-PCR) methods were utilized to examine methylation status of CDH1 gene promoter and the changes of E-cadherin mRNA in colon carcinoma cell line HT-29 before and after the treatment with 5-Aza-CdR. The expression of E-cadherin and localization of β-catenin were labeled by immunofluorescence and analyzed under a laser scanning confocal microscope. Results (1) CDH1 gene promoter methylation was positive and unmethylation was negative in HT-29 cells before the treatment with 5-Aza-CdR. After treatment with 5-Aza-CdR for 24 h, methylation turned negative and unmethylation was detected; (2) The E-cadherin mRNA failed to be amplified in cells, whereas it could be detected after the treatment. The mRNA expression level of E-cadherin expressed as average gray ratio was 0. 491 ± 0. 011 and 0. 568 ±0. 013 respectively after treatment with 1 and 2 μmoL/L 5-Aza-CdR (P 〈 0. 05 ; (3) Before treatment with 5-Aza-CdR, the expression of E-cadherin was not detected and β-catenin was detected in cytoplasm and nucleus, while both E-cadherin and β-catenin staining was positive on the cell membrane by immunofluorescence after the treatment. With the expression of E-cadherin induced by 5-Aza-CdR, the membranous expression of β-catenin was elevated and nuclear expression of β-catenin was reduced. Immunofuorescence double staining displayed the distribution of β-catenin was corresponded with E-cadherin on the cell membrane. Conclusion CDH1 gene promoter methylation may lead to the loss of E-eadherin expression and the altered distribution of β-eatenin in colon carcinoma cells.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2011年第11期1909-1911,共3页 Chinese Journal of Experimental Surgery
基金 云南省社会发展科技计划基金资助项目(2007CA009)
关键词 上皮钙黏素 Β-连接素 结肠癌 甲基化 E-cadherin β-catenin Colon carcinoma Methylation
  • 相关文献

参考文献7

  • 1卢秀波,刘洋,殷德涛,邱新光,王庆兆.乳头状甲状腺癌中S100A4、E-钙黏素的表达及其意义[J].中华实验外科杂志,2007,24(1):31-32. 被引量:8
  • 2Tamura G,Yin J,Wang S,et al.E-cadherin gene promoter hypermethylation in primary human gastric cancers.J Natl Cancer Inst,2000,92:569-573.
  • 3Tchufikov NA.Molecular mechanisms of epigenetics.Biochemistry,2005,70:406-423.
  • 4Lugli A,Zlobec Ⅰ,Minoo P,et al.Prognostic significance of the Wnt signalling pathway molecules APC,β-catenin and E-cadherin in colorectal cancer:a tissue microarray-based analysis.Histopathology,2007,50:453-464.
  • 5Maekawa M,Watanabe Y.Epigenetics:Relations to disease and laboratory findings.Curr Med Chem,2007,14:2642-2653.
  • 6Broday L,Cai J,Costa M.Nickel enhances telomeric silencing in Saccharomyces cereviseae.Mutat Res,1999,440:121-130.
  • 7刘小方,姜宏,张翠生,于绍平,王在秋,苏海龙.5-氮-2-脱氧胞苷调控p53-bax凋亡通路DNA甲基化对胆管癌细胞生长的影响[J].中华实验外科杂志,2010(7):876-878. 被引量:5

二级参考文献20

  • 1卢秀波,安兆峰,王庆兆,殷德涛,邱新光.Survivin和c-myc在分化型甲状腺癌中的表达及临床意义[J].中华实验外科杂志,2004,21(6):705-706. 被引量:18
  • 2张东伟,杨维良.甲状腺癌基因治疗的现状及展望[J].中华实验外科杂志,2005,22(2):255-256. 被引量:16
  • 3祝学光.肿瘤分子靶向治疗进展[J].中华实验外科杂志,2005,22(11):1285-1286. 被引量:11
  • 4闫朝岐,杨维良.胆管癌基因研究现状及展望[J].中华实验外科杂志,2005,22(11):1413-1414. 被引量:5
  • 5Cheung HW,Jin DY,ling MT,et al.Mitotic arrest deficient 2 expression induces chemosensitization to a DNA-damaging agent,cisplatin,in nasopharyngeal carcinoma cells.Cancer Res,2005,65:1450-1458.
  • 6Schuler M,Green DR.Mechanisms of p53-dependent apoptosis.Biochemical Society Transactions,2001,29:684-688.
  • 7Singhal D,Van Gulik TM,Gourna DJ.Palliative management of hilar cholangiocarcinoma.Surg Oncol,2005,14:59274-59276.
  • 8Lujambio A,Esteller M.CpG island hypemiethylation of tumor suppressor microRNAs in human cancer.Cell Cycle,2007,6:455-1459.
  • 9Xiong J,Epstein RJ.Growth inhibition of human cancer cells by 5-aza-2'-deoxycytidine does not correlate with its effects on INK4a/ARF expression or initial promoter methylation status.Mol Cancer Ther,2009,8:779-785.
  • 10Wijermans PW,Lübbert M,Verhoef G,et al.An epigenetic approach to the treatment of advanced MDS;the experience with the DNA dem-ethylating agent 5-aza-2 '-deoxycytidine (decitabine) in 177 patients.Ann Hematol,2005,84:9-17.

共引文献11

同被引文献22

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部